Journal of Medical Economics, Volume 22, Issue 3 (2019)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 22, Issue 3 (2019)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Volume 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Oncology

Article
A review and validation of overall survival extrapolation in health technology assessments of cancer immunotherapy by the National Institute for Health and Care Excellence: how did the initial best estimate compare to trial data subsequently made available?
Ash Bullement, Yang Meng, Miranda Cooper, Dawn Lee, Tara Louise Harding, Chris O’Regan & Raquel Aguiar-Ibanez
Pages: 205-214
Published online: 30 Nov 2018
AbstractforA review and validation of overall survival extrapolation in health technology assessments of cancer immunotherapy by the National Institute for Health and Care Excellence: how did the initial best estimate compare to trial data subsequently made available? | Full Text | References | PDF (1.4 MB) | EPUB
  • 3704 Views
  • 15 CrossRef citations
  • 0Altmetric
Free Access

Neurology

Article
Cost-utility analysis of levodopa carbidopa intestinal gel (Duodopa) in the treatment of advanced Parkinson’s disease in patients in Scotland and Wales
Svetlana Kalabina, Jonathan Belsey, Dominic Pivonka, Biju Mohamed, Chris Thomas & Brian Paterson
Pages: 215-225
Published online: 12 Dec 2018
AbstractforCost-utility analysis of levodopa carbidopa intestinal gel (Duodopa) in the treatment of advanced Parkinson’s disease in patients in Scotland and Wales | Full Text | References | PDF (1.2 MB) | EPUB
  • 2822 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost-utility analysis of alemtuzumab in comparison with interferon beta, fingolimod, and natalizumab treatment for relapsing-remitting multiple sclerosis in Austria
Evelyn Walter, Thomas Berger, Barbara Bajer-Kornek & Florian Deisenhammer
Pages: 226-237
Published online: 21 Dec 2018
AbstractforCost-utility analysis of alemtuzumab in comparison with interferon beta, fingolimod, and natalizumab treatment for relapsing-remitting multiple sclerosis in Austria | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 1788 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Gastroenterology

Article
An economic evaluation of perioperative enteral nutrition in patients undergoing colorectal surgery (SANICS II study)
Madhuri Pattamatta, Silvia M. A. A. Evers, Boudewijn J. J. Smeets, Emmeline G. Peters, Misha D. P. Luyer & Mickael Hiligsmann
Pages: 238-244
Published online: 21 Dec 2018
AbstractforAn economic evaluation of perioperative enteral nutrition in patients undergoing colorectal surgery (SANICS II study) | Full Text | References | PDF (1.1 MB) | EPUB
  • 900 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Cardiovascular Medicine

Article
Constructing a value-based healthcare system for hypertensive patients through changing payment mode: evidence from a comparative study in rural China
Yudong Miao, Xiangdong Yuan, Jianqin Gu, Liang Zhang, Ruibo He, Sandeep Sandeep & Jian Wu
Pages: 245-251
Published online: 17 Jan 2019
AbstractforConstructing a value-based healthcare system for hypertensive patients through changing payment mode: evidence from a comparative study in rural China | Full Text | References | PDF (721.1 KB) | EPUB | Supplemental
  • 1059 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Health Policy

Article Commentary
Decrease in American birth rates makes it imperative for the United States to implement state mandated fertility coverage
Samer Tannus & Michael H. Dahan
Pages: 252-253
Published online: 04 Jan 2019
AbstractforDecrease in American birth rates makes it imperative for the United States to implement state mandated fertility coverage | Full Text | References | PDF (239.3 KB) | EPUB
  • 1756 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access

Diabetes

Article
The impact of anti-vascular endothelial growth factor agents on visual impairment/blindness prevention in patients with diabetic macular edema and on associated patient and caregiver burden in Japan
Shigehiko Kitano, Taiji Sakamoto, Rei Goto, Ayako Fukushima, Anne-Lise Vataire & Yusuke Hikichi
Pages: 254-265
Published online: 09 Jan 2019
AbstractforThe impact of anti-vascular endothelial growth factor agents on visual impairment/blindness prevention in patients with diabetic macular edema and on associated patient and caregiver burden in Japan | Full Text | References | PDF (1.1 MB) | EPUB
  • 1758 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Wound Management

Article
Hospital patients with severe wounds: early evidence on the impact of Medicare payment changes on treatment patterns and outcomes
Berna Demiralp, Samuel Soltoff & Lane Koenig
Pages: 266-272
Published online: 05 Jan 2019
AbstractforHospital patients with severe wounds: early evidence on the impact of Medicare payment changes on treatment patterns and outcomes | Full Text | References | PDF (603.2 KB) | EPUB | Supplemental
  • 596 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Psychiatry

Article
Real-world evidence of improved healthcare utilization in patients with schizophrenia or schizoaffective disorder after early treatment of paliperidone palmitate once-monthly treatment in Hong Kong
June W. Y. Choon, David B. C. Wu, H. Y. Chong, William T. L. Lo, Catherine S. Y. Chong, W. S. Chung, Eileena M. C. Chui, Brian Tomlinson, Vivian W. Y. Lee, S. C. Lee & Kenneth K. C. Lee
Pages: 273-279
Published online: 14 Jan 2019
AbstractforReal-world evidence of improved healthcare utilization in patients with schizophrenia or schizoaffective disorder after early treatment of paliperidone palmitate once-monthly treatment in Hong Kong | Full Text | References | PDF (946.1 KB) | EPUB
  • 1134 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Diabetes

Article
Economic modelling of costs associated with outcomes reported for type 2 diabetes mellitus (T2DM) patients in the CANVAS and EMPA-REG cardiovascular outcomes trials
Rhiannon Kamstra, Mike Durkin, Jennifer Cai, Brahim Bookhart, Marie-Hélène Lafeuille, Dominic Pilon, Sean Tiggelaar, Ameur M. Manceur & Patrick Lefebvre
Pages: 280-287
Published online: 11 Jan 2019
AbstractforEconomic modelling of costs associated with outcomes reported for type 2 diabetes mellitus (T2DM) patients in the CANVAS and EMPA-REG cardiovascular outcomes trials | Full Text | References | PDF (842.9 KB) | EPUB
  • 1303 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Intensive care unit improves dialysis care quality while reducing costs
Tara Greenleaf Nichols et al.
Research Letter | Published online: 7 Jun 2024
Open Access
The efficiency of TAVI in intermediate and low-risk Japanese patients
Panagiotis Petrou
Editorial | Published online: 7 Jun 2024
Open Access
Analysis of long-term clinical and cost impact of etranacogene dezaparvovec for the treatment of hemophilia B population in the United States
Songkai Yan et al.
Article | Published online: 6 Jun 2024
Open Access
Cost-effectiveness analysis of mosunetuzumab for treatment of relapsed or refractory follicular lymphoma after two or more lines of systemic therapy in the United States
Matthew Matasar et al.
Article | Published online: 6 Jun 2024
Open Access
View all latest articles